NO20004818L - Stabile doseringsformer av fluoxetin og dets enantiomere - Google Patents
Stabile doseringsformer av fluoxetin og dets enantiomereInfo
- Publication number
- NO20004818L NO20004818L NO20004818A NO20004818A NO20004818L NO 20004818 L NO20004818 L NO 20004818L NO 20004818 A NO20004818 A NO 20004818A NO 20004818 A NO20004818 A NO 20004818A NO 20004818 L NO20004818 L NO 20004818L
- Authority
- NO
- Norway
- Prior art keywords
- fluoxetine
- enantiomers
- dosage forms
- stable dosage
- stable
- Prior art date
Links
- RTHCYVBBDHJXIQ-MRXNPFEDSA-N (R)-fluoxetine Chemical compound O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=C(C(F)(F)F)C=C1 RTHCYVBBDHJXIQ-MRXNPFEDSA-N 0.000 title abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002464 fluoxetine Drugs 0.000 title abstract 2
- 239000002552 dosage form Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/049,227 US20030013740A1 (en) | 1998-03-27 | 1998-03-27 | Stable dosage forms of fluoxetine and its enantiomers |
| PCT/US1999/006601 WO1999049857A1 (en) | 1998-03-27 | 1999-03-25 | Stable dosage forms of fluoxetine and its enantiomers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004818D0 NO20004818D0 (no) | 2000-09-26 |
| NO20004818L true NO20004818L (no) | 2000-11-23 |
Family
ID=21958714
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004818A NO20004818L (no) | 1998-03-27 | 2000-09-26 | Stabile doseringsformer av fluoxetin og dets enantiomere |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20030013740A1 (pt) |
| EP (1) | EP1067918A1 (pt) |
| JP (1) | JP2002509882A (pt) |
| KR (1) | KR20010034703A (pt) |
| CN (1) | CN1303280A (pt) |
| AU (1) | AU3205399A (pt) |
| BR (1) | BR9909118A (pt) |
| CA (1) | CA2325858A1 (pt) |
| NO (1) | NO20004818L (pt) |
| WO (1) | WO1999049857A1 (pt) |
| ZA (1) | ZA200005189B (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6372919B1 (en) * | 2001-01-11 | 2002-04-16 | Dov Pharmaceutical, Inc. | (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent |
| US6258853B1 (en) | 2001-01-31 | 2001-07-10 | Grayson Walker Stowell | Form a of fluoxetine hydrochloride |
| US6316672B1 (en) | 2001-01-31 | 2001-11-13 | Grayson Walker Stowell | Form a of fluoxetine hydrochloride |
| US6310250B1 (en) | 2001-01-31 | 2001-10-30 | Grayson Walker Stowell | Form A of fluoxetine hydrochloride |
| US6313350B1 (en) | 2001-01-31 | 2001-11-06 | Grayson Walker Stowell | Form a of fluoxetine hydrochloride |
| US6310251B1 (en) | 2001-01-31 | 2001-10-30 | Grayson Walker Stowell | Form a of fluoxetine hydrochloride |
| US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
| US20080045725A1 (en) | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
| EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
| MX2008014024A (es) | 2006-05-04 | 2008-11-14 | Boehringer Ingelheim Int | Formas poliformas. |
| PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
| PE20091730A1 (es) | 2008-04-03 | 2009-12-10 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
| US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
| EA024980B1 (ru) | 2009-02-17 | 2016-11-30 | КРКА, д.д., НОВО МЕСТО | Лекарственные формы, содержащие основание прасугреля или его фармацевтически приемлемые соли присоединения кислоты, и способы их приготовления |
| AR083878A1 (es) | 2010-11-15 | 2013-03-27 | Boehringer Ingelheim Int | Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento |
| NZ722096A (en) | 2011-12-15 | 2016-11-25 | Alkermes Pharma Ireland Ltd | Prodrugs of secondary amine compounds |
| EP4151218A1 (en) | 2012-05-14 | 2023-03-22 | Boehringer Ingelheim International GmbH | Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis |
| MX378004B (es) * | 2015-12-02 | 2025-03-10 | Jaime Samuel CHAIT AUERBACH | Composición oral veterinaria con gabapentina. |
| US10155000B2 (en) | 2016-06-10 | 2018-12-18 | Boehringer Ingelheim International Gmbh | Medical use of pharmaceutical combination or composition |
| CN107334744B (zh) * | 2017-07-24 | 2020-09-04 | 湖南洞庭药业股份有限公司 | 盐酸美金刚药物组合物和制法 |
| CN107334742B (zh) * | 2017-08-18 | 2020-01-31 | 山东力诺制药有限公司 | 一种盐酸氟西汀分散片及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4594358A (en) * | 1985-02-25 | 1986-06-10 | Eli Lilly And Company | Analgesic method |
| CH678920A5 (pt) * | 1989-11-14 | 1991-11-29 | Gergely Gerhard | |
| CA2134038C (en) * | 1994-06-16 | 1997-06-03 | David Taiwai Wong | Potentiation of drug response |
| ATE265205T1 (de) * | 1996-02-09 | 2004-05-15 | Quadrant Drug Delivery Ltd | Feste arzneimittel enthaltend trehalose |
| EP0792649A1 (en) * | 1996-02-29 | 1997-09-03 | Eli Lilly And Company | Treatment of sleep disorders |
| CA2175939C (en) * | 1996-05-07 | 1999-09-14 | Michael Warnett Hetherington | Manual capsule filling device |
| ES2227707T3 (es) * | 1996-07-15 | 2005-04-01 | Alza Corporation | Nuevas formulaciones para la administracion transdermica de acetato de fluoxetina y de maleato de fluoxetina. |
| US5830500A (en) * | 1996-07-22 | 1998-11-03 | Pentech Pharmaceuticals, Inc. | Low dose fluoxetine tablet |
-
1998
- 1998-03-27 US US09/049,227 patent/US20030013740A1/en not_active Abandoned
-
1999
- 1999-03-25 CN CN99806619A patent/CN1303280A/zh active Pending
- 1999-03-25 JP JP2000540823A patent/JP2002509882A/ja active Pending
- 1999-03-25 KR KR1020007010708A patent/KR20010034703A/ko not_active Withdrawn
- 1999-03-25 CA CA002325858A patent/CA2325858A1/en not_active Abandoned
- 1999-03-25 AU AU32053/99A patent/AU3205399A/en not_active Abandoned
- 1999-03-25 WO PCT/US1999/006601 patent/WO1999049857A1/en not_active Ceased
- 1999-03-25 EP EP99914151A patent/EP1067918A1/en not_active Withdrawn
- 1999-03-25 BR BR9909118-6A patent/BR9909118A/pt not_active IP Right Cessation
-
2000
- 2000-09-26 NO NO20004818A patent/NO20004818L/no unknown
- 2000-09-27 ZA ZA200005189A patent/ZA200005189B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3205399A (en) | 1999-10-18 |
| CN1303280A (zh) | 2001-07-11 |
| NO20004818D0 (no) | 2000-09-26 |
| US20030013740A1 (en) | 2003-01-16 |
| WO1999049857A1 (en) | 1999-10-07 |
| EP1067918A1 (en) | 2001-01-17 |
| BR9909118A (pt) | 2001-10-16 |
| CA2325858A1 (en) | 1999-10-07 |
| ZA200005189B (en) | 2001-05-22 |
| KR20010034703A (ko) | 2001-04-25 |
| JP2002509882A (ja) | 2002-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20004818L (no) | Stabile doseringsformer av fluoxetin og dets enantiomere | |
| EE200300212A (et) | Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks | |
| DK1023050T3 (da) | Nye formuleringer af farmakologiske midler, fremgangsmåder til fremstillingen deraf og fremgangsmåder til anvendelsen deraf | |
| ATE289640T1 (de) | Amidofunktionelle aminopolydiorganosiloxane | |
| IS6957A (is) | Tatrat sölt af 5,8,14,-tríasatetrasýkló[10.3.1.02,11.04,9]-hexadeka-2(11),3,5,7,9,-pentaen og lyfjafræðilegar samsetningar af þeim | |
| DK1787639T3 (da) | Stabile farmaceutiske formuleringer til tryksamme dosisinhalatorer | |
| DE60224284D1 (de) | Stabile formulierung von modifiziertem glp-1 | |
| DE60044041D1 (de) | Exendine zur Glucagon Suppression | |
| ATE258928T1 (de) | Respiratorisches syncytialvirus replikation inhibitoren | |
| ATE259796T1 (de) | Respiratorisches syncytialvirus replikation inhibitoren | |
| MXPA03007712A (es) | Sales farmaceuticas. | |
| SE0100901D0 (sv) | New composition | |
| BR0209580A (pt) | Derivados de ciclohexan-1, 4 diamina substituìdos | |
| NO20005224D0 (no) | BTK inhibitorer og fremgangsmÕter for deres identifikasjon og anvendelse | |
| ITRM20020264A0 (it) | Articolo assorbente e procedimento per la sua fabbricazione. | |
| DK1417206T3 (da) | Hidtil ukendte 2H-pyridazin-3-on-derivater, farmaceutiske præparater indeholdende det samme, og en fremgangsmåde til fremstilling af den aktive bestanddel | |
| NO20006138L (no) | Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter | |
| DK1185253T3 (da) | Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac | |
| DK1033990T3 (da) | 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud | |
| DK1957037T3 (da) | Farmaceutisk præparat til nasal anvendelse af fentanyl | |
| EE200300501A (et) | Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid | |
| NO20010219D0 (no) | Polycykliske tiazolidin-2-yliden aminer, fremgangsmåte for deres fremstilling og deres anvendelse som legemiddel | |
| BR0114395A (pt) | Composição farmacêutica para administração por suprimento via oral | |
| DE60111503D1 (de) | Pharmazeutische zusammensetzungen enthaltend terbinafin | |
| CY1106712T1 (el) | Υποκατεστημενα παραγωγα 5-αμινο-1-πεντεν-3-ολης |